Value of Blood Transfusion in Patients With a Blood Hematocrit of 24% to 30% After Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 104, Issue 8, 2009, Pages 1069-1073

  Maluenda, Gabriel ^a   Lemesle, Gilles ^a   Ben Dor, Itsik ^a   Collins, Sara D ^a   Syed, Asmir I ^a   Li, Yanlin ^a   Torguson, Rebecca ^a   Kaneshige, Kimberly ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEATH; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD TRANSFUSION; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HEMORRHAGE; HUMANS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 70349582992     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.006     Document Type: Article

References (20)

1. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., Hochman J.S., Krumholz H.M., Lamas G.A., Mullany C.J., Pearle D.L., Sloan M.A., Smith Jr. S.C., Anbe D.T., Kushner F.G., Ornato J.P., Pearle D.L., Sloan M.A., Jacobs A.K., Adams C.D., Anderson J.L., Buller C.E., Creager M.A., Ettinger S.M., Halperin J.L., Hunt S.A., Lytle B.W., Nishimura R., Page R.L., Riegel B., Tarkington L.G., and Yancy C.W. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 51 (2008) 210-247
2. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey Jr. D.E., Chavey II W.E., Fesmire F.M., Hochman J.S., Levin T.N., Lincoff A.M., Peterson E.D., Theroux P., Wenger N.K., Wright R.S., Smith Jr. S.C., Jacobs A.K., Halperin J.L., Hunt S.A., Krumholz H.M., Kushner F.G., Lytle B.W., Nishimura R., Ornato J.P., Page R.L., and Riegel B. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 116 (2007) e148-e304
3. Gibbons R.J., Abrams J., Chatterjee K., Daley J., Deedwania P.C., Douglas J.S., Ferguson Jr. T.B., Fihn S.D., Fraker Jr. T.D., Gardin J.M., O'Rourke R.A., Pasternak R.C., Williams S.V., Gibbons R.J., Alpert J.S., Antman E.M., Hiratzka L.F., Fuster V., Faxon D.P., Gregoratos G., Jacobs A.K., and Smith Jr. S.C. ACC/AHA 2002 Guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003 (2002) 149-158
4. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., Peterson E.D., Schulman K.A., and Califf R.M. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
5. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabaté M., Suttorp M.J., Baumgart D., Seyfarth M., Pfisterer M.E., and Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
6. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308 (1994) 81-106
7. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
8. Manoukian S.V., Voeltz M.D., and Eikelboom J. Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk. Clin Cardiol 30 Suppl 2 (2007) II24-II34
9. Ndrepepa G., Berger P.B., Mehilli J., Seyfarth M., Neumann F.J., Schömig A., and Kastrati A. Periprocedural bleeding and 1-year outcome after percutaneous coronary intervention. J Am Coll Cardiol 51 (2008) 690-697
10. Kinnaird T.D., Stabile E., Mintz G.S., Lee C.W., Canos D.A., Gevorkian N., Pinnow E.E., Kent K.M., Pichard A.D., Satler L.F., Weissman N.J., Lindsay J., and Fuchs S. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92 (2003) 930-935
11. Yang X., Alexander K.P., Chen A.Y., Roe M.T., Brindis R.G., Rao S.V., Gibler W.B., Ohman E.M., Peterson E.D., and CRUSADE Investigators. The implications of blood transfusion for patients with a non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 46 (2005) 1490-1495
12. Kim P., Dixon S., Eisenbrey A.B., O'Malley B., Boura J., and O'Neill W. Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention. Clin Cardiol 30 Suppl 2 (2007) II-35-II-43
13. Rao S.V., Jollis J.G., Harrington R.A., Granger C.B., Newby L.K., Armstrong P.W., Moliterno D.J., Lindblad L., Pieper K., Topol E.J., Stamler J.S., and Califf R.M. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
14. Alexander K.P., Chen A.Y., Wang T.Y., Rao S.V., Newby L.K., LaPointe N.M., Ohman E.M., Roe M.T., Boden W.E., Harrington R.A., Peterson E.D., and CRUSADE Investigators. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J 155 (2008) 1047-1053
15. Hébert P.C., Wells G., Blajchman M.A., Marshall J., Martin C., Pagliarello G., Tweeddale M., Schweitzer I., Yetisir E., Transfusion Requirements in Critical Care Investigators, and Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340 (1999) 409-417
16. Thygesen K., Alpert J.S., and White H.D. Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007) 2173-2195
17. Welch H.G., Meehan K.R., and Goodnough L.T. Prudent strategies for elective red blood cell transfusion. Ann Intern Med 116 (1992) 393-402
18. Morisaki H., and Sibbald W.J. Tissue oxygen delivery and the microcirculation. Crit Care Clin 20 (2004) 213-223
19. Casutt M., Seifert B., Pasch T., Schmid E.R., Turina M.I., and Spahn D.R. Factors influencing the individual effects of blood transfusions on oxygen delivery and oxygen consumption. Crit Care Med 27 (1999) 2194-2200
20. Madjdpour C., and Spahm D.R. Allogenic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 95 (2005) 33-42